tradingkey.logo
tradingkey.logo
Suchen

908 Devices Inc.

MASS
Zur Watchlist hinzufügen
6.900USD
-0.400-5.48%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
260.91MMarktkapitalisierung
VerlustKGV TTM

908 Devices Inc.

6.900
-0.400-5.48%

mehr Informationen über 908 Devices Inc. Unternehmen

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

908 Devices Inc. Informationen

BörsenkürzelMASS
Name des Unternehmens908 Devices Inc
IPO-datumDec 18, 2020
CEOKnopp (Kevin J)
Anzahl der mitarbeiter246
WertpapierartOrdinary Share
GeschäftsjahresendeDec 18
Addresse44 Third Avenue
StadtBURLINGTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01803
Telefon19787294478
Websitehttps://908devices.com/
BörsenkürzelMASS
IPO-datumDec 18, 2020
CEOKnopp (Kevin J)

Führungskräfte von 908 Devices Inc.

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.34M
--
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
925.56K
-2.16%
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
75.26K
--
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
--
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
--
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Mr. John Kenneweg
Mr. John Kenneweg
Vice President - Government
Vice President - Government
--
--
Mr. Joseph H. (Joe) Griffith, IV
Mr. Joseph H. (Joe) Griffith, IV
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Michael Scott Turner, J.D.
Mr. Michael Scott Turner, J.D.
Chief Legal and Administrative Officer, Company Secretary
Chief Legal and Administrative Officer, Company Secretary
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.34M
--
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
925.56K
-2.16%
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
75.26K
--
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
--
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
--
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Device sales revenue
36.66M
65.23%
Recurring revenue
19.42M
34.56%
Contract revenue
117.00K
0.21%
Nach RegionUSD
Name
Umsatz
Anteil
United States
41.25M
73.40%
Europe,Middle East & Africa
10.43M
18.55%
Asia Pacific
3.00M
5.33%
Americas other
1.52M
2.71%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Device sales revenue
36.66M
65.23%
Recurring revenue
19.42M
34.56%
Contract revenue
117.00K
0.21%

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
ARCH Venture Partners
15.14%
First Light Asset Management, LLC
12.79%
ARK Investment Management LLC
5.15%
BlackRock Institutional Trust Company, N.A.
4.37%
Knopp (Kevin J)
3.54%
Andere
59.02%
Aktionäre
Aktionäre
Anteil
ARCH Venture Partners
15.14%
First Light Asset Management, LLC
12.79%
ARK Investment Management LLC
5.15%
BlackRock Institutional Trust Company, N.A.
4.37%
Knopp (Kevin J)
3.54%
Andere
59.02%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
28.01%
Investment Advisor
23.04%
Venture Capital
15.20%
Individual Investor
8.95%
Hedge Fund
3.93%
Pension Fund
0.93%
Research Firm
0.76%
Bank and Trust
0.11%
Insurance Company
0.03%
Andere
19.04%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
247
28.68M
75.86%
-11.07M
2025Q4
230
33.42M
92.33%
-4.73M
2025Q3
224
29.28M
81.15%
-3.78M
2025Q2
226
29.86M
82.76%
-3.27M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
ARCH Venture Partners
5.73M
15.32%
--
--
Apr 17, 2025
First Light Asset Management, LLC
4.84M
12.94%
+155.33K
+3.32%
Dec 31, 2025
ARK Investment Management LLC
1.99M
5.31%
+32.21K
+1.65%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.65M
4.42%
+56.15K
+3.52%
Dec 31, 2025
Knopp (Kevin J)
1.34M
3.58%
+73.23K
+5.79%
Feb 02, 2026
Brown (Christopher D)
985.56K
2.64%
+23.44K
+2.44%
Feb 01, 2026
Needham Investment Management L.L.C.
770.00K
2.06%
+548.00K
+246.85%
Dec 31, 2025
Geode Capital Management, L.L.C.
688.57K
1.84%
+16.48K
+2.45%
Dec 31, 2025
First Eagle Investment Management, L.L.C.
623.88K
1.67%
+19.92K
+3.30%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
ARK Genomic Revolution ETF
1.43%
State Street SPDR S&P Kensho Future Security ETF
0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
0.5%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Mehr Anzeigen
ARK Genomic Revolution ETF
Anteil1.43%
State Street SPDR S&P Kensho Future Security ETF
Anteil0.86%
State Street SPDR S&P Kensho New Econ Comp ETF
Anteil0.5%
iShares Micro-Cap ETF
Anteil0.04%
Avantis US Small Cap Equity ETF
Anteil0.02%
iShares Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI